General MedicationsORALStandard

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE

Standard Dose

1MG;240MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE is listed in Drugs@FDA under application 079135 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 1MG;240MG Sponsor GLENMARK PHARMS LTD Submission history Latest submission status date: 2020-04-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE is listed in Drugs@FDA under application 079135 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 1MG;240MG Sponsor GLENMARK PHARMS LTD Submission history Latest submission status date: 2020-04-14 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.